PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS

NCT03520088 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-06-25

No results posted yet for this study

Summary

Purpose: The "Total Mesorectal Excision" (TME) is the standard surgical technique for the treatment of rectal cancer. Up to 50% of sexual dysfunction is described after TME and up to 30% of urinary dysfunction. The main objective of the study is to compare pre- and post-TME sexual dysfunction according to the approach of the inferior mesenteric vessels, directly on the IMA or from the inferior mesenteric vein (IMV) to the IMA.

Methods: Multicenter, prospective, controlled and randomized study of patients with rectal adenocarcinoma with neoadjuvant chemoradiotherapy, who will be randomized into two groups depending on the approach of the inferior mesenteric vessels. The main variable is pre and postoperative sexual dysfunction. The sample to be included will be 90 patients, 45 per group.

Conditions

Interventions

PROCEDURE

Inferior mesenteric Vein dissection

Dissection of the Inferior mesenteric Vein first, and go down to the Artery during the total mesorectal excision

PROCEDURE

Inferior mesenteric Artery dissection

Dissection of the Inferior mesenteric Artery directly in the total mesorectal excision

Sponsors & Collaborators

  • Paula Planelles-Soler

    collaborator UNKNOWN
  • Laura Mora-Lopez

    collaborator UNKNOWN
  • Naim Hannaoui

    collaborator UNKNOWN
  • Sheila Serra-Pla

    collaborator UNKNOWN
  • Arturo Dominguez-Garcia

    collaborator UNKNOWN
  • Jesus Muñoz-Rodriguez

    collaborator UNKNOWN
  • Joan Prats-Lopez

    collaborator UNKNOWN
  • Salvador Navarro-Soto

    collaborator UNKNOWN
  • Xavier Serra-Aracil

    collaborator UNKNOWN
  • Corporacion Parc Tauli

    lead OTHER

Principal Investigators

  • Anna Pallisera-Lloveras, MD, PhD · Corporacio Parc Tauli. Parc Tauli University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-03
Primary Completion
2021-12-30
Completion
2022-12-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03520088 on ClinicalTrials.gov